News
Early detection key to improving treatment of uveitis, a leading cause globally of vision loss
New treatment guidance has been developed to help doctors tackle uveitis — one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help thousands of sufferers keep this...
Ciliatech appoints world-class panel of eyecare specialists to newly created KOL advisory board
Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...
Biomarkers reveal how patients with glaucoma may respond to treatment
Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers at UCL and Moorfields Eye Hospital.
Dr Paul Singh and Prof Gus Gazzard on laser as first line therapy
Both the American Academy of Ophthalmology (AAO) and the European Glaucoma Society (EGS) have updated their preferred practice regimens to recognize or recommend SLT as an initial intervention for glaucoma and the NICE UK are now guiding doctors to use SLT before drops.
CHEC announces launch of two new treatment centres
CHEC, a leading provider of community-based ophthalmology and endoscopy services in the UK, is delighted to announce the opening of two new sites in Stockport and Sheffield.
